DRD2 and hepatocellular carcinoma: It has been reported that DRD2 agonists can effectively inhibit the proliferation and metastasis of HCC cells [17], although there are still no reports on the effects of DRD3 on liver cancer, including the prognosis and biological behavior of HCC.